7 doctors weighed in:

Does taking tamoxifen benefit women with cdis?

7 doctors weighed in
Dr. Barry Rosen
Surgery
5 doctors agree

In brief: Yes.

Women with a history of ductal-carcinoma-in-situ (dcis) may have a 50% reduction in developing a second breast cancer when taking tamoxifen for 5 years ("chemoprevention").
Furthermore, following a lumpectomy, the combination of tamoxifen and radiation therapy may have a decreased risk of cancer recurrence in the affected breast greater than either therapy alone.

In brief: Yes.

Women with a history of ductal-carcinoma-in-situ (dcis) may have a 50% reduction in developing a second breast cancer when taking tamoxifen for 5 years ("chemoprevention").
Furthermore, following a lumpectomy, the combination of tamoxifen and radiation therapy may have a decreased risk of cancer recurrence in the affected breast greater than either therapy alone.
Dr. Barry Rosen
Dr. Barry Rosen
Thank
Dr. Eric Brown
Breast Surgery

In brief: Yes

When you have hormone sensitive (er/pr +) dcis, tamoxifen is the appropriate endocrine therapy.
In fact, it's the only hormonal therapy for this type of cancer at this time. Tamoxifen will also reduce the risk of developing a different breast cancer by 50%.

In brief: Yes

When you have hormone sensitive (er/pr +) dcis, tamoxifen is the appropriate endocrine therapy.
In fact, it's the only hormonal therapy for this type of cancer at this time. Tamoxifen will also reduce the risk of developing a different breast cancer by 50%.
Dr. Eric Brown
Dr. Eric Brown
Thank
Get help from a real doctor now
Dr. Mark Pack
Board Certified, Surgery
27 years in practice
3M people helped
Continue
108,000 doctors available
Read more answers from doctors